174 related articles for article (PubMed ID: 1386404)
21. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment.
Tzotzas T; Krassas GE; Konstantinidis T; Bougoulia M
Thyroid; 2000 Sep; 10(9):803-8. PubMed ID: 11041458
[TBL] [Abstract][Full Text] [Related]
22. Changes in serum lipoprotein(a) and lipids during treatment of hyperthyroidism.
Kung AW; Pang RW; Lauder I; Lam KS; Janus ED
Clin Chem; 1995 Feb; 41(2):226-31. PubMed ID: 7874776
[TBL] [Abstract][Full Text] [Related]
23. Lipoprotein(a) and apolipoprotein(a) in a New World monkey, the common marmoset (Callithrix jacchus). Association of variable plasma lipoprotein(a) levels with a single apolipoprotein(a) isoform.
Guo HC; Michel JB; Blouquit Y; Chapman MJ
Arterioscler Thromb; 1991; 11(4):1030-41. PubMed ID: 1829630
[TBL] [Abstract][Full Text] [Related]
24. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy.
Arem R; Patsch W
Arch Intern Med; 1990 Oct; 150(10):2097-100. PubMed ID: 2222095
[TBL] [Abstract][Full Text] [Related]
25. Lipoprotein(a) in subjects with familial defective apolipoprotein B100.
Perombelon YF; Gallagher JJ; Myant NB; Soutar AK; Knight BL
Atherosclerosis; 1992 Feb; 92(2-3):203-12. PubMed ID: 1385954
[TBL] [Abstract][Full Text] [Related]
26. Lipoprotein (a), low-density, intermediate-density lipoprotein, and blood pressure in a young male population.
Steinmetz A; Kirklies A; Schlosser G; Cassel W; Peter JH; Ehlenz K; Schäfer JR; Wichert PV; Kaffarnik H
Clin Investig; 1993 Feb; 71(2):145-9. PubMed ID: 8461626
[TBL] [Abstract][Full Text] [Related]
27. Changes in plasma triglyceride levels shift lipoprotein(a) density in parallel with that of LDL independently of apolipoprotein(a) size.
Nakajima K; Hinman J; Pfaffinger D; Edelstein C; Scanu AM
Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1238-43. PubMed ID: 11451758
[TBL] [Abstract][Full Text] [Related]
28. Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis.
Utermann G; Hoppichler F; Dieplinger H; Seed M; Thompson G; Boerwinkle E
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4171-4. PubMed ID: 2524837
[TBL] [Abstract][Full Text] [Related]
29. The relationship between lipoprotein(a) and low density lipoprotein receptors during the treatment of hyperthyroidism.
Hayashi H; Mizushima N; Yoshinaga H; Kawamitsu H; Matsuda S; Tanoue M; Kurosawa H; Fujimoto H; Amakawa T
Horm Metab Res; 1996 Aug; 28(8):384-7. PubMed ID: 8886825
[TBL] [Abstract][Full Text] [Related]
30. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
31. Plasma lipoprotein (a) concentrations in hypothyroid, euthyroid and hyperthyroid subjects.
Erem C; Değer O; Bostan M; Orem A; Sönmez M; Ulusoy S; Telatar M
Acta Cardiol; 1999 Apr; 54(2):77-81. PubMed ID: 10378018
[TBL] [Abstract][Full Text] [Related]
32. Changes in the distribution and composition of high-density lipoproteins in primary hypothyroidism.
Muls E; Rosseneu M; Lamberigts G; De Moor P
Metabolism; 1985 Apr; 34(4):345-53. PubMed ID: 3920475
[TBL] [Abstract][Full Text] [Related]
33. LDL physical properties, lipoprotein and Lp(a) levels in acromegalic patients. Effects of octreotide therapy. Italian Multicenter Octreotide Study Group.
Arosio M; Sartore G; Rossi CM; Casati G; Faglia G; Manzato E
Atherosclerosis; 2000 Aug; 151(2):551-7. PubMed ID: 10924734
[TBL] [Abstract][Full Text] [Related]
34. Dyslipoproteinaemia in hypothyroidism of pituitary origin: effects of L-thyroxine substitution on lipoprotein lipase, hepatic lipase, and on plasma lipoproteins.
Valdemarsson S; Hedner P; Nilsson-Ehle P
Acta Endocrinol (Copenh); 1983 Jun; 103(2):192-7. PubMed ID: 6858552
[TBL] [Abstract][Full Text] [Related]
35. Association of Lp(a) rather than integrally-bound apo(a) with triglyceride-rich lipoproteins of human subjects.
Marcoux C; Lussier-Cacan S; Davignon J; Cohn JS
Biochim Biophys Acta; 1997 Jun; 1346(3):261-74. PubMed ID: 9219911
[TBL] [Abstract][Full Text] [Related]
36. Correlation of apolipoprotein(a) isoproteins with Lp(a) density and distribution in fasting plasma.
Reblin T; Rader DJ; Beisiegel U; Greten H; Brewer HB
Atherosclerosis; 1992 Jun; 94(2-3):223-32. PubMed ID: 1385958
[TBL] [Abstract][Full Text] [Related]
37. Normal lipoprotein(a) concentrations and apolipoprotein(a) isoforms in patients with insulin-dependent diabetes mellitus.
Klausen IC; Schmidt EB; Lervang HH; Gerdes LU; Ditzel J; Faergeman O
Eur J Clin Invest; 1992 Aug; 22(8):538-41. PubMed ID: 1425859
[TBL] [Abstract][Full Text] [Related]
38. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
[TBL] [Abstract][Full Text] [Related]
39. Lipoprotein (a) levels in thyroid dysfunction before and after treatment.
Sucić M; Bozikov V; Mesić R; Sokolić L
Croat Med J; 1998 Mar; 39(1):19-22. PubMed ID: 9475802
[TBL] [Abstract][Full Text] [Related]
40. Effects of ezetimibe on remnant-like particle cholesterol, lipoprotein (a), and oxidized low-density lipoprotein in patients with dyslipidemia.
Nozue T; Michishita I; Mizuguchi I
J Atheroscler Thromb; 2010 Feb; 17(1):37-44. PubMed ID: 20075599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
